316 related articles for article (PubMed ID: 38187072)
21. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
Tian H; Chen S; Zhang C; Li M; Zheng H
Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J
J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.
Li G; Liu Y; Su Z; Ren S; Zhu G; Tian Y; Qiu Y
Eur J Cancer; 2013 Jul; 49(11):2596-607. PubMed ID: 23583221
[TBL] [Abstract][Full Text] [Related]
24. Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma.
Fu Y; Liang X; Yang X; Liu J; Huang H; Zhang P; Li S; Zhu D; Zhang Y; Peng F; Chen Y; Chen Z
Mol Cell Proteomics; 2023 Jun; 22(6):100567. PubMed ID: 37172717
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma.
Liu X; Luo HN; Tian WD; Lu J; Li G; Wang L; Zhang B; Liang BJ; Peng XH; Lin SX; Peng Y; Li XP
Cancer Biol Ther; 2013 Dec; 14(12):1133-42. PubMed ID: 24025417
[TBL] [Abstract][Full Text] [Related]
26. MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma.
Tian Y; Tang L; Yi P; Pan Q; Han Y; Shi Y; Rao S; Tan S; Xia L; Lin J; Oyang L; Tang Y; Liang J; Luo X; Liao Q; Wang H; Zhou Y
J Cancer; 2020; 11(13):3976-3985. PubMed ID: 32328201
[TBL] [Abstract][Full Text] [Related]
27. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
[TBL] [Abstract][Full Text] [Related]
28. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.
Gong Z; Yang Q; Zeng Z; Zhang W; Li X; Zu X; Deng H; Chen P; Liao Q; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G
Tumour Biol; 2016 Mar; 37(3):3683-95. PubMed ID: 26462838
[TBL] [Abstract][Full Text] [Related]
29. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
30. The emerging roles of exosomal miRNAs in nasopharyngeal carcinoma.
Liao C; Liu H; Luo X
Am J Cancer Res; 2021; 11(6):2508-2520. PubMed ID: 34249413
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
[TBL] [Abstract][Full Text] [Related]
32. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma.
Luan J; Wang J; Su Q; Chen X; Jiang G; Xu X
Oncotarget; 2016 Mar; 7(9):10513-21. PubMed ID: 26824418
[TBL] [Abstract][Full Text] [Related]
34. Advances in Research on microRNAs Related to the Invasion and Metastasis of Nasopharyngeal Carcinoma.
Zhang S; Wang B; Zheng L; Fu Z; Fu Y; Huang W; Cheng A
Curr Mol Pharmacol; 2022; 15(3):463-474. PubMed ID: 34126919
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
36. miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.
Qiu F; Sun R; Deng N; Guo T; Cao Y; Yu Y; Wang X; Zou B; Zhang S; Jing T; Ling T; Xie J; Zhang Q
PLoS One; 2015; 10(3):e0120969. PubMed ID: 25786138
[TBL] [Abstract][Full Text] [Related]
37. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W; Chan JY; Wong TS
Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
[TBL] [Abstract][Full Text] [Related]
38. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
Shaw P; Senthilnathan R; Krishnan S; Suresh D; Shetty S; Muthukaliannan GK; Mani RR; Sivanandy P; Chandramoorthy HCK; Gupta MM; Baxi S; Jayaraj R
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503179
[No Abstract] [Full Text] [Related]
39. Profiling miRNAs in nasopharyngeal carcinoma FFPE tissue by microarray and Next Generation Sequencing.
Peng J; Feng Y; Rinaldi G; Levine P; Easley S; Martinez E; Hashmi S; Sadeghi N; Brindley PJ; Mulvenna JP; Bethony JM; Plieskatt JL
Genom Data; 2014 Dec; 2():285-9. PubMed ID: 26484110
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing.
Li G; Qiu Y; Su Z; Ren S; Liu C; Tian Y; Liu Y
PLoS One; 2013; 8(12):e84486. PubMed ID: 24367666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
